Sandrine Houzé

A Worldwide Map of<i>Plasmodium falciparum</i>K13-Propeller Polymorphisms

Didier Ménard, Nimol Khim, Johann Beghain et al. · New England Journal of Medicine · 2016 · 542 citations · Full text

Polymorphisms in Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors That Affect Treatment Outcomes for P. falciparum Malaria After Artemether-Lumefantrine and Artesunate-Amodiaquine

Meera Venkatesan, Nahla B. Gadalla, Kasia Stepniewska et al. · American Journal of Tropical Medicine and Hygiene · 2014 · 292 citations · Full text

Antiparasitic Agent, Malaria, Genetic Epidemiology +18

Cutaneous Larva Migrans in Travelers: A Prospective Study, with Assessment of Therapy with Ivermectin

Olivier Bouchaud, Sandrine Houzé, Ricarda Schiemann et al. · Clinical Infectious Diseases · 2000 · 131 citations · Full text

Vector-borne Pathogen, June 1994, Parasitic Disease +12

Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial

Laurent Mandelbrot, François Kieffer, Rémi Sitta et al. · American Journal of Obstetrics and Gynecology · 2018 · 112 citations

Maternal Immunization, Prenatal Therapy, Pediatrics +5

Assessment of the Drug Susceptibility of <i>Plasmodium falciparum</i> Clinical Isolates from Africa by Using a <i>Plasmodium</i> Lactate Dehydrogenase Immunodetection Assay and an Inhibitory Maximum Effect Model for Precise Measurement of the 50-Percent Inhibitory Concentration

Halima Kaddouri, Serge Nakache, Sandrine Houzé et al. · Antimicrobial Agents and Chemotherapy · 2006 · 100 citations · Full text

Therapeutic Drug Monitoring, Drug Analysis, Drug Susceptibility +14